Team size: 12

Which recent political, economic, or regulatory changes have impacted the company and the team the most?

The Covid-19 pandemic threatened the sustainability of healthcare ecosystem in Türkiye. The interruption of health services primarily limited patients’ access to hospitals, innovative diagnostics, and treatment solutions. As a pharmaceutical organisation, we are constantly seeking the way to serve our patients with the best possible service while providing help to our community. The past two years have been challenging as we constantly had to demonstrate our full potential of agile, innovative, and hardworking nature to our patients as well as the industry. The ongoing Covid-19 pandemic played a key role in shaping the policy agenda for different countries, and it created regulatory roadblocks as countries require different approval requirements and procedures. We believe that a better and more accessible health service is possible for everyone; and the pharma sector plays a significant role in catalysing health system transformation.

What do you think are the biggest risks facing the healthcare industry at the moment and how are you preparing your company and team to face these risks?

The ever-increasing population, higher life expectancy, increase in chronic diseases and difficulties in accessing healthcare, place a heavier burden on the healthcare industry. Unexpected health crises like the Covid-19 pandemic can additionally aggravate this burden in respect of capacity strains and budget pressures. Roche sees it as our main responsibility to create the efficient and sustainable healthcare systems of the future and to unlock the true potential of advances in medicine on the journey toward a healthier society. Within the scope of our global 2030 vision, we are opening the door to a new era where we can offer twice as much medical development to patients by reducing the burden of cost on society by half through innovative solutions, services, and collaborations. Building such future requires us to go beyond the usual working models, both internally and externally. We are developing different business models to further integrate all our stakeholders into our work and make our company structure much more benefit-oriented for the entire health ecosystem.

Even in the best-case scenario, Covid is likely to have far-reaching ramifications. How are you safeguarding the long-term health of the business?

Since the beginning of the pandemic, we continued to identify and support treatments for the disease. In these exceptional times, we are supporting the communities, governments, healthcare providers and everyone else working towards the common goal to tackle the evolving Covid -19 pandemic. Digitalisation, which is one of the building blocks of our company, has become even more important both globally and locally with the effect of the pandemic.